NMS after clozapine initiation

J Am Acad Child Adolesc Psychiatry. 2005 Nov;44(11):1101-2. doi: 10.1097/01.chi.0000177328.92333.2b.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Adolescent
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects*
  • Benzodiazepines / administration & dosage
  • Benzodiazepines / adverse effects
  • Child
  • Child Development Disorders, Pervasive / drug therapy*
  • Clozapine / administration & dosage
  • Clozapine / adverse effects*
  • Creatine Kinase / blood
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Drug Therapy, Combination
  • Humans
  • Injections, Intramuscular
  • Male
  • Neuroleptic Malignant Syndrome / diagnosis
  • Neuroleptic Malignant Syndrome / etiology*
  • Olanzapine
  • Schizophrenia / drug therapy*

Substances

  • Antipsychotic Agents
  • Benzodiazepines
  • Creatine Kinase
  • Clozapine
  • Olanzapine